Asia - Pacific Anticoccidial Drugs Market - Forecast to 2020
Asia - Pacific Anticoccidial Drugs Market - Trends and Forecasts (2017 - 2022)


DEC 2017

Asia - Pacific Anticoccidial Drugs Market - Trends and Forecasts (2017 - 2022)

Purchase Report

The Asia Pacific market is the fastest growing market for anticoccidials. This is primarily due to the increased demand for meat proteins in countries like China, India, Malaysia etc. The increased demand for meat proteins has increased the meat production in the region. China is the leading contributor in this region. The region is characterized by a myriad of small players in the market both for Meat production as well as antimicrobial agent production. This is leading to a price war as these cheap alternatives are giving the multinationals a run for their money. The Asia pacific market for anticoccidials has grown at a CAGR of 8.4% from 2016 to 2021 and the growth is expected to continue during the forecasted period. Currently very little regulations are in place leaving the market unorganized and open for competition to enter.

The Market research report titled Asia - Pacific Anticoccidial Drugs Market In Animal Health - Trends And Forecasts - (2016-21) by MORDOR INTELLIGENCE categorizes the global anticoccidial market on the basis of Animal Types (Poultry, Cattle, Swine, and companion animals), by Drugs (Ionophore anticoccidials, Chemical derivative anticoccidials and Antibiotic anticoccidials) and by Geography (China, India, Japan & Australia).

Key players in the Anticoccidial Drugs Market are Zoetis, Elanco (A division of Eli Lilly and Company), Merial, Bayer Health care Animal Healthcare division, Merck Animal Healthcare, Boehringer Ingelheim Animal Health, Virbac, and Novartis Animal Healthcare.

What the report offers:

  • Market Definition for the specified topic along with identification of key drivers and restraints for the market.
  • Market analysis for the Asia - Pacific Anticoccidial Drugs Market in Healthcare Industry, with region specific assessments and competition analysis on a regional scale.
  • Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
  • Identification and analysis of the Macro and Micro factors that affect the Asia - Pacific Anticoccidial Drugs Market in Healthcare Industry on regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

1 Introduction

2 Market Definition  

3 Market Drivers  

4 Market Restraints  

5 Market opportunities  

6 Anticoccidial drugs


6.2Asia Pacific Market

6.3Coccidiosis in Poultry

6.3.1Commonly used anticoccidials in poultry

6.3.2Drug administration modes and Dosage

6.4Coccidiosis in Cattle

6.4.1Commonly used anticoccidials in cattle

6.4.2 Drug administration modes and dosage

6.4.3 Commonly used coccidiostats in cattle

6.5 Coccidiosis in Swine

6.5.1 Commonly used anticoccidials in Swine

6.5.2 Drug Administration modes and dosage

6.6 Coccidiosis in companion animals

6.6.1 Coccidiosis in dogs

6.6.2 Coccidiosis in cats

6.6.3 Commonly used anticoccidials for Dogs, Dosage and mode of administration

6.6.4 Commonly used anitcoccidials for cats, dosage and modes of Administration

6.7 Anticoccidials market by types of drugs

6.7.1 Ionophore anticoccidials

6.7.2 Chemical derivative anticoccidials

6.7.3 Antibiotic anticoccidials

  7 Country wise analysis of anticoccidial market ( Market size, Forecast and CAGR)

7.1 Introduction

7.2 China

7.3 India

7.4 Japan

7.4 Australia

  8. Segmentation by Animal Type - APAC anticoccidial market ( Market size, Forecast and CAGR)

8.1. Introduction

8.2. Swine

8.3 Poultry

8.4 Fish

8.5 Runinant

  9 The future of anticoccidial market   10 Competitive Landscape

10.1 Introduction

10.2 Top contenders in the market

  11 Company Profiles


Dosch Pharmaceuticals


  12 Disclaimer  

Purchase Report

Our Clients Include View All

Looking to Customize Report?